Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 10061-10070 of 13616

Page
per page
  1. RSVA 405
    B7759 RSVA 405
    Summary: AMPK activator
      <15.62 mg/mL
  2. MLN2238
    A4008 MLN2238
     3 Citation
    Summary: β5 site of the 20S proteasome inhibitor
  3. Apoptosis Activator 2
    A4016 Apoptosis Activator 2
    Summary: Indoledione caspase activator, cell-permeable
      Soluble in DMSO
  4. Radicicol
    A4067 Radicicol
     5 Citation
    Summary: ATPase/kinase inhibitor
      Soluble in ethanol
  5. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     6 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  6. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
  7. 3-aminobenzamide
    A4161 3-aminobenzamide
     2 Citation
    Summary: Potent PARP inhibitor
      ≥23.45 mg/mL
  8. 2-Methoxyestradiol (2-MeOE2)
    A4188 2-Methoxyestradiol (2-MeOE2)
     2 Citation
    Summary: Apoptotic, antiproliferative and antiangiogenic agent
      insoluble in H2O; ≥15.25 mg/mL
  9. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    Target: HCV Proteases
    Summary: HCV NS3/4A protease inhibitor
      ≥32.6 mg/mL
  10. MC1568
    A4094 MC1568
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Class II HDAC inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL

Items 10061-10070 of 13616

Page
per page